biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Post by deadpatienton May 06, 2014 5:05pm

244 Views

Post# 22530989

Agree DRJ

This thing is going to be a lot bigger than any of us can Imagine, forget about stock promotion for a while, this will be EPIC. The Michael Smith lab at UBC is world class. This will put its stamp as a place where insurmountable roadblocks in biotech science can be overcome. HOLD ON BOYS AND GIRLS ,THIS WILL BE THE STORY OF THE YEAR>

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario